Litecoin Surges 24% as MEI Pharma Boosts Treasury with $100M Investment

Generated by AI AgentCoin World
Tuesday, Aug 12, 2025 2:21 pm ET2min read
Aime RobotAime Summary

- MEI Pharma's $100M Litecoin investment boosted open interest by 40%, driving a 24% price surge despite a 3% crypto market decline.

- Pi Network (PI) maintains community optimism near $0.36 despite price forecasts, supported by security upgrades and Stellar Protocol 23.

- Cold Wallet's $270M Plus Wallet acquisition secured 2M users, offering 3,632% ROI potential via CWT cashback incentives and rapid adoption.

- Institutional support elevates Litecoin's stability, while Cold Wallet's financial model and instant user base position it as 2025's fastest-growing crypto project.

Litecoin has experienced a notable shift in price dynamics in 2025, driven in part by MEI Pharma's $100 million investment into Litecoin’s treasury, which led to a 40% increase in open interest despite a broader 3% decline in the crypto market [1]. Following this strategic move,

settled around $116 after a 24% monthly gain, signaling renewed interest in the asset as both a payment method and an inflation hedge. Analysts have pointed out that institutional purchases like this often serve as catalysts for long-term price stability and increased adoption [2].

Meanwhile,

Network (PI), currently trading near $0.36, has seen strong community-driven optimism despite forecasts suggesting a potential drop to $0.28 [3]. The project has introduced several upgrades to bolster its platform, including the launch of Passkey, a one-tap security solution, and the upcoming Protocol 23, which will enable smart contracts and faster transactions. These developments reinforce Pi Network’s positioning as a project with strong technical foundations and community engagement, making it an appealing speculative asset for cautious investors.

Cold Wallet, a newer entrant, is generating significant attention due to its rapid user acquisition and presale growth potential. The project acquired Plus Wallet for $270 million, instantly securing over 2 million active users and establishing a cashback system that rewards transactions in its native token, CWT. At the current presale stage, Cold Wallet tokens are priced at $0.00998, with a confirmed listing price of $0.3517, offering a theoretical 3,632% return on investment [4]. Over $5.9 million has been raised so far, with more than 703 million tokens sold. Unlike traditional wallets that do not offer integrated financial incentives, Cold Wallet’s model directly ties usage to value accumulation, making it a compelling alternative to established platforms [5].

The broader market is beginning to distinguish between short-term speculative hype and long-term structural advantages as it approaches the end of 2025. Litecoin’s resurgence is being driven by corporate adoption and institutional support, while Pi Network’s bullish momentum is fueled by a loyal and active community. However, Cold Wallet’s rapid user acquisition and financial incentives set it apart as a project with immediate and scalable impact. With its user base already in place, Cold Wallet is positioned to outpace many of its peers in terms of both growth and adoption [6].

[1] MEI Pharma’s $100 million investment into Litecoin significantly boosted open interest.

[2] Analysts suggest that large institutional purchases can stabilize and elevate cryptocurrency prices.

[3] Forecasts indicate Pi Network could see a decline, but community confidence remains strong.

[4] Cold Wallet’s presale price and listing price suggest a 3,632% potential ROI.

[5] Cold Wallet differentiates itself from competitors with a cashback model rewarding users in CWT.

[6] Analysts note that Cold Wallet’s instant user base and financial model give it a significant edge in 2025.

Source: [1] MEI Pharma’s $100M

Move Lifts Open Interest by 40% [https://coinmarketcap.com/community/articles/689b8226d6feb946e822b694/](https://coinmarketcap.com/community/articles/689b8226d6feb946e822b694/)

Comments



Add a public comment...
No comments

No comments yet